Abstract
Huoxue Huayu therapy (HXHY) has been widely used to treat cardiovascular diseases in traditional Chinese medicine (TCM) such as hypertension and coronary heart disease (CHD). The present study describes a meta-analysis of a series of prospective randomized, double-blind, placebo-controlled trials conducted to evaluate the effect of HXHY on patients with CHD after percutaneous coronary intervention (PCI). The Cochrane Library, PubMed, EMBASE, the China National Knowledge Infrastructure (CNKI), the Chinese Biomedical Literature database, and the Wanfang database were searched up until June 2018. A series of randomized controlled clinical trials were included and the subjects were patients with CHD who had undergone PCI. The experimental group was treated with HXHY therapy, and the control group was treated with placebo; meanwhile, all the patients accepted conventional Western medicine. Review Manager 5.3 software was used for the statistical analysis. Ten trials were included in the final study. The overall risk of bias assessment was low. HXHY had a greater beneficial effect on reducing the in-stent restenosis (ISR) rate (RR = 0.57, 95% confidence interval [CI] [0.40-0.80], P=0.001) and the degree of restenosis (MD = -8.89, 95%...Continue Reading
References
Feb 1, 1995·Journal of the American College of Cardiology·J A SpertusS D Fihn
May 31, 2002·International Journal of Cardiology·Marc HorlitzJosef Niebauer
Feb 24, 2006·JAMA : the Journal of the American Medical Association·Marie-Claude MoriceUNKNOWN REALITY Trial Investigators
Jun 11, 2010·Chinese Journal of Integrative Medicine·Fu-yong ChuZhi-zhong Li
Aug 31, 2010·European Heart Journal·UNKNOWN Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardDavid Taggart
May 25, 2011·Journal of Ethnopharmacology·Wei-Rong WangFeng Ren
Jul 7, 2011·Circulation·Anthony S Kim, S Claiborne Johnston
Jul 28, 2011·The Canadian Journal of Cardiology·Sanjiv Khangura, Wendy L Gordon
Jun 7, 2012·Applied Health Economics and Health Policy·Georgia KourlabaNikos Maniadakis
Sep 15, 2012·Heart and Vessels·Igor MrdovicJovan Perunicic
Jul 31, 2013·Chinese Journal of Integrative Medicine·Gui Yu, Jie Wang
Oct 12, 2013·Science China. Life Sciences·Yue LiuKeji Chen
Nov 26, 2013·Journal of Ethnopharmacology·Wei Zhou, Yonghua Wang
Jun 24, 2014·Computers in Biology and Medicine·Hao GuYanjiang Qiao
Jun 28, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Huan-Lin WuXin-Min Ruan
Nov 2, 2014·Current Vascular Pharmacology·Xing-Jiang XiongJ Wang
Jun 13, 2015·Chinese Journal of Integrative Medicine·Dan-Ping XuChao-Yang Zheng
Jan 27, 2016·Circulation·UNKNOWN Writing Group MembersUNKNOWN Stroke Statistics Subcommittee
Aug 10, 2016·Heart·Héctor BuenoFrans Van de Werf
Citations
Jun 6, 2019·Frontiers in Pharmacology·Yan MaShui Yu
Jun 9, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Bailu DuanFang Huang
Mar 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Fei LinChao Liu
Jan 13, 2021·Chinese Journal of Integrative Medicine·Qing-Rong LiuYong-Jian Wu
Dec 9, 2020·Medicine·Yize SunHaibin Zhao
Jan 19, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Fan ZhangZhe Zhang